Logo image
Timo Huber, MD working place, Immuno-Oncology Center Cologne
Timo Huber, MD
Excellent
AiroScore
9.30

Timo Huber, MD

immunology, oncology
immunology, oncology
User ScoreExperienceRatingPrice RangeOnline Consultations
95%16 years9.3/10$$$$No

Overview

Country, City
Germany, Cologne
Health facility
Immuno-Oncology Center Cologne
Medical unit
Department of oncology, immunotherapy, and cancer vaccines

About the doctor

Dr. med. Timo Huber is a highly specialized physician at the Immun-Onkologisches Zentrum Köln (IOZK), where he focuses on the clinical application of multimodal immunotherapy for cancer patients. His medical career is distinguished by a deep integration of traditional oncological principles with the latest advancements in tumor immunology. At the IOZK, he is instrumental in developing and supervising personalized treatment protocols that include dendritic cell vaccinations and oncolytic virus therapies, tailored to each patient's tumor's unique genetic profile. In his clinical practice, Dr. Huber is known for his analytical approach to diagnostics and his ability to translate complex immunological data into actionable therapeutic strategies. He works as part of an international multidisciplinary team, providing expert consultation to patients seeking alternative and complementary immunotherapy options when standard treatments have been exhausted. His commitment to patient care is characterized by a high degree of empathy and a focus on evidence-based biological medicine. Dr. Huber actively contributes to IOZK’s mission to advance personalized oncology, ensuring that patients receive a comprehensive, supportive, and scientifically grounded treatment experience.

Resume

CV (Curriculum Vitae)

Education
  • 2004-2010 Degree in Medicine (MD), Medical Faculty of the University of Cologne
  • 2011-2012 Doctoral Thesis (Dr. med.), Institute of Virology, University of Cologne
  • 2012-2017 Specialized Residency Training in Internal Medicine and Oncology, University Hospital Cologne
  • 2018-2019 Advanced Certification in Clinical Tumor Immunology and Viral Therapy
Experience
  • 2012-2017 Resident Physician, Department of Internal Medicine and Hematology-Oncology, University Hospital Cologne
  • 2017-2019 Clinical Researcher focusing on T-cell responses and Cancer Vaccination, Cologne
  • 2019-2022 Consultant Physician and Immunotherapy Specialist, Immun-Onkologisches Zentrum Köln (IOZK)
  • 2022 Senior Staff Physician and Head of Clinical Diagnostics, Immun-Onkologisches Zentrum Köln (IOZK)
Awards & Memberships
  • 2010 Licensed Physician (Approbation), North Rhine Medical Association (Äekno)
  • 2014 Member of the German Cancer Society (Deutsche Krebsgesellschaft)
  • 2017 Research Grant for Innovative Studies in Personalized Immunotherapy
  • 2020 Active Member of the European Society for Medical Oncology (ESMO)
  • 2023 Clinical Leadership Excellence Award, IOZK

Languages

English flag
English
German flag
German

Location

Hohenstaufenring, 30-32, 50674 Cologne, Germany

FAQ

Where does the doctor practice?

What is the specialization of Timo Huber, MD?

The primary specialization of the doctor is immunology, oncology.

What is the experience of the specialist?

Timo Huber, MD has been practicing for more than 16 years.

What is the rating of the doctor?

Timo Huber, MD is rated as 9.30 by AiroMedical.

Does the specialist offer online consultations?

No, Timo Huber, MD doesn’t perform virtual appointments.

Timo Huber, MD
Timo Huber, MD

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Timo Huber, MD

Similar Doctors

Excellent
AiroScore
9.90
Immuno-Oncology Center Cologne
oncology, personalized cancer vaccine, immunotherapy
Excellent
AiroScore
9.70
University Hospital Cologne
internal medicine, hematology, and oncology
Excellent
AiroScore
9.60
University Hospital Cologne
pancreatic cancer, GI oncology, internal medicine
Excellent
AiroScore
9.50
Excellent
AiroScore
9.50
Excellent
AiroScore
9.50
Excellent
AiroScore
9.40
Excellent
AiroScore
9.10
Excellent
AiroScore
10.00
University Hospital Charité Berlin
haematology, oncology, leukaemia research, tumor immunology